319 related articles for article (PubMed ID: 8313392)
41. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
[TBL] [Abstract][Full Text] [Related]
42. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
Maki Y
Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
[TBL] [Abstract][Full Text] [Related]
43. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Dingemanse J; Hussain Y; Korn A
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
[TBL] [Abstract][Full Text] [Related]
44. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
Fitton A; Faulds D; Goa KL
Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119
[TBL] [Abstract][Full Text] [Related]
45. Monoamine oxidase B inhibition and the "cheese effect".
Youdim MB; Finberg JP
J Neural Transm Suppl; 1987; 25():27-33. PubMed ID: 3480939
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
[TBL] [Abstract][Full Text] [Related]
47. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
Bieck PR; Antonin KH; Schmidt E
Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
[TBL] [Abstract][Full Text] [Related]
48. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; McIntyre IM; White K
J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
[TBL] [Abstract][Full Text] [Related]
49. Bovril and moclobemide: a novel therapeutic strategy for central autonomic failure.
Karet FE; Dickerson JE; Brown J; Brown MJ
Lancet; 1994 Nov; 344(8932):1263-5. PubMed ID: 7967987
[TBL] [Abstract][Full Text] [Related]
50. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
51. Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit.
Maeda I; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E; Oguchi K; Yasuhara H
Jpn J Ophthalmol; 1988; 32(2):211-8. PubMed ID: 3184554
[TBL] [Abstract][Full Text] [Related]
52. [Moclobemide (Aurorix), the first MAO-A-inhibitor: really something new?].
Nolen WA; Birkenhäger TK; Moleman P
Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1492-6. PubMed ID: 1495565
[No Abstract] [Full Text] [Related]
53. Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor moclobemide.
Dingemanse J; Guentert T; Gieschke R; Stabl M
J Cardiovasc Pharmacol; 1996 Dec; 28(6):856-61. PubMed ID: 8961085
[TBL] [Abstract][Full Text] [Related]
54. [Monoamine oxidase inhibitors and pressor response to dietary amines].
Tipton KF
Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
[TBL] [Abstract][Full Text] [Related]
55. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
Burkard W; d'Agostini F; Kettler R; Da Prada M
Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137
[TBL] [Abstract][Full Text] [Related]
56. Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.
Ametamey SM; Beer HF; Guenther I; Antonini A; Leenders KL; Waldmeier PC; Schubiger PA
Nucl Med Biol; 1996 Apr; 23(3):229-34. PubMed ID: 8782230
[TBL] [Abstract][Full Text] [Related]
57. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
Oxenkrug GF; Requintina PJ; Yuwiler A
J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
[TBL] [Abstract][Full Text] [Related]
58. Pharmacology of moclobemide.
Haefely W; Burkard WP; Cesura A; Colzi A; Kettler R; Lorez HP; Martin JR; Moreau JL; Richards JG; Schaffner R
Clin Neuropharmacol; 1993; 16 Suppl 2():S8-18. PubMed ID: 8313402
[TBL] [Abstract][Full Text] [Related]
59. [Selective inhibition of monoamine oxidase in bovine brain by befol and moclobemide].
Moskvitina TA; Gankina EM; Val'dman AV
Vopr Med Khim; 1991; 37(2):49-51. PubMed ID: 1897195
[TBL] [Abstract][Full Text] [Related]
60. Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.
Korn A; Eichler HG; Fischbach R; Gasic S
Psychopharmacology (Berl); 1986; 88(2):153-7. PubMed ID: 3081926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
